Evidence map›Paper›PMID 40128476›Full record

ReviewAdvances in experimental medicine and biology2025

Adult Hippocampal Neurogenesis as a Therapeutic Target in Fetal Alcohol Spectrum Disorder.

Lee Anna Cunningham, Elif Tunc-Ozcan, Arasely M Rodriguez

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lee Anna CunninghamDepartment of Neurosciences, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA. leeanna@salud.unm.edu.
Elif Tunc-OzcanDepartment of Neurosciences, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Arasely M RodriguezDepartment of Neurosciences, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.

Funding

Understanding neurophysiological deficits in response inhibition in children with FASDP50AA022534 · NIAAA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Carlos Fernando Valenzuela · 2014 to 2026
$21.5M
Neural activity and circuitry-mediated hippocampal stress responsesR00MH125016 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI TUNC-OZCAN, ELIF · 2023 to 2025
$747k
Therapeutic Targeting of Adult Hippocampal Neurogenesis in a Mouse Model of FASDF31AA031920 · NIAAA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI RODRIGUEZ, ARASELY M · 2024 to 2025
$86k
NIAAA NIH HHS F31 AA031920NIAAA NIH HHS P50 AA022534NIMH NIH HHS R00 MH125016
6 · The paper itself

Abstract

This review is focused on adult hippocampal neurogenesis as a potential therapeutic target in fetal alcohol spectrum disorder (FASD). Adult hippocampal neurogenesis refers to the production of new hippocampal dentate granule cells (DGCs) from a replenishable pool of neural stem and progenitor cells throughout life. Adult-generated DGCs have been shown to exert a profound influence on hippocampal network activity in experimental animals and have been implicated in the regulation of many hippocampal-dependent behaviors and emotional states, including certain forms of learning and memory, anxiety, mood, and stress resilience. While adult hippocampal neurogenesis in humans remains controversial, many studies support its existence and impact on hippocampal function in human health and disease. Here, we review mechanisms of adult hippocampal neurogenesis under physiological conditions, as described primarily in rodent brain, its impact on network activity and behavior, and the negative effects of developmental alcohol exposure on this process. We then explore hippocampal neurogenesis as a potential target for FASD therapy using pharmacological and neurophysiological approaches known to stimulate adult hippocampal neurogenesis, currently available for clinical use in FASD patients.

Indexed as

Fetal Alcohol Spectrum DisordersHippocampusNeurogenesisAdultAnimalsDentate GyrusFemaleHumansNeural Stem CellsPregnancyAdult hippocampal neurogenesisAntidepressantsDentate gyrusFASDGestational alcohol exposurePrenatal alcohol exposureTranscranial stimulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.